Results 291 to 300 of about 79,137 (303)

The Association of Aging With Von Willebrand Factor Levels and Bleeding Risk in Type 1 Von Willebrand Disease

Clinical and Applied Thrombosis/Hemostasis, 2018
Craig D Seaman
exaly  

Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery

Journal of Thrombosis and Haemostasis, 2019
Flora Peyvandi, Nicola Curry
exaly  

Classification and Characterization of Hereditary Types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (Unclassifiable) von Willebrand Disease

Clinical and Applied Thrombosis/Hemostasis, 2006
Zwi N Berneman, Alain Gadisseur, Marc van Der Planken   +2 more
exaly  

Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology

Best Practice and Research in Clinical Haematology, 2001
C Mazurier, J Goudemand, L Hilbert
exaly  

von Willebrand factor and von Willebrand disease [published erratum appears in Blood 1988 Mar;71(3):830]

Blood, 1987
Zm Ruggeri, Ts Zimmerman
exaly  

Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis

Haemophilia, 2015
Barbara A Konkle
exaly  

Von Willebrand factor and von Willebrand disease

Von Willebrand disease (vWD) is an autosomally inherited bleeding disorder caused by a deficiency or abnormality of von Willebrand factor (vWF). vWF is a large multimeric glycoprotein that mediates platelet adhesion at the site of vessel injury. Also, it protects factor VIII from proteolytic degradation in the circulation. vWD has a prevalence of about
openaire   +1 more source

VON WILLEBRAND DISEASE SAN DIEGO, A NEW VARIANT

Lancet, The, 1976
exaly  

von Willebrand disease and von Willebrand factor

Thrombosis Research, 1993
openaire   +1 more source

von Willebrand Disease and von Willebrand Factor

Clinics in Laboratory Medicine
Bailey Hutchison, Andrew Podd, Sandra L. Haberichter   +2 more
openaire   +1 more source